谷歌决定关闭Google Health,科技巨头们医疗健康雄心不在?

2021-08-21 JACKZHAO MedSci原创

据美国CNBC等媒体报道,谷歌将决定关闭其健康部门(Google Health),媒体援引谷歌内部备忘录报道了这一事件。这份备忘录是周四由谷歌人工智能研究机构负责人杰夫·迪恩 (Jeff

据美国CNBC等媒体报道,谷歌将决定关闭其健康部门(Google Health),媒体援引谷歌内部备忘录报道了这一事件。这份备忘录是周四由谷歌人工智能研究机构负责人杰夫·迪恩 (Jeff Dean) 发给员工的,谷歌健康部门是该机构的一部分。

Jeff Dean给员工内部信中说道,在该部门工作的员工将搬到公司的其他部门。一个开发软件以帮助医生搜索患者记录的 Google Health 团队将从现在开始直接向Dean汇报。另一个团队正在探索将机器学习应用于处理医学图像等任务的方法,该团队将加入由谷歌搜索和人工智能副总裁Yossi Matias 领导的团队。

这一决定是伴随美国著名电子健康记录服务公司Cerner周四宣布,谷歌健康副总裁 David Feinberg将于10月成为Cerner 的首席执行官兼总裁,接替现任首席执行官Brent Shafer。Cerner,是美国最大的电子健康记录服务提供商之一,也是一家几乎完全专注于为医疗专业人士提供软件的公司,而不是信息技术巨头的一个部门。Feinberg曾经是一名医生,拥有 MBA 学位。Cerner 在公告中说,在加入谷歌之前,他领导了医疗保健提供商 Geisinger,并且是加州大学洛杉矶分校医院的首席执行官。消息公布后,Cerner 股价上涨约 0.5%,全年涨幅超过 1%。

David Feinberg自2018年谷歌健康成立以来一直领导谷歌的医疗保健计划,其职位是在他被聘用时创建的。David Feinberg离开谷歌表明,这家搜索巨头可能正在重新评估其在谷歌健康部门开发新产品的雄心,以打入价值数万亿美元的健康技术市场。“真正的压力是‘这真的会帮助数百万人吗?’”David Feinberg在 6 月份的一次会议上说。“是谷歌规模吗?这就是压力。”

在谷歌期间,David Feinberg参与的一个项目是与苹果合作开发Covid-19追踪软件,他还谈到使用YouTube 为医生和其他护理人员提供可靠信息。Feinberg在6月份表示,另一个重点是 Care Studio,这是与 Ascension 合作组织患者电子健康记录的合作伙伴。

该公司仍在探索谷歌母公司 Alphabet 不同部门的其他健康技术,包括通过谷歌云与医疗公司的合作伙伴关系。据 CNBC 当时报道,截至2020年2月,谷歌健康拥有500多名员工,David Feinberg向谷歌人工智能负责人Jeff Dean报告。当时还表示,他在谷歌的老板并没有就医疗团队的收入向他施压。

该公司表示:“谷歌深信技术在改善健康方面的力量,我们增加了整个公司的健康投资。” “我们感谢David Feinberg在过去几年中的领导和指导,帮助加快我们的健康工作,并祝他一切顺利。”该公司没有宣布谷歌健康新领导层,但正在进行的努力将继续进行。

尽管关闭了谷歌健康,但医疗保健行业有望继续成为谷歌的主要关注点。这家搜索巨头今年早些时候完成了对 Fitbit公司的 21 亿美元收购,Fitbit 是一家具有健康追踪功能的智能手表制造商。 Fitbit的智能手表主要面向消费者销售,但这些设备也被医疗保健提供者用作患者护理计划的一部分,并被研究人员用于支持临床试验。

医疗保健无疑仍将是谷歌云业务的主要关注点。在过去几年中,Google Cloud 收集了大量解决方案,旨在帮助医院等组织更有效地处理医疗数据。最新添加的是医疗保健数据引擎,这是一项组织医疗信息以使其更易于分析的服务,从而帮助研究人员更快地找到见解,例如优化临床试验的方法。

谷歌母公司 Alphabet 有两个专门专注于医疗保健行业的部门,这些部门将在谷歌健康关闭后继续运营。它们是该公司的 Calico 和 Verily 生命科学子公司。Verily 是两家子公司中最大的一家,已从谷歌母公司Alphabet和外部投资者那里筹集了超过 20 亿美元的资金。

谷歌发言人在昨日报告发布后的一份声明中说:“谷歌深信技术在改善健康方面的力量,我们增加了整个公司的健康投资。” “这包括在 Google Health 内部开发项目,在搜索、地图和 YouTube 上推出和扩展覆盖数十亿人的与健康相关的功能,并欢迎Fitbit带来的价值。”

不仅仅是谷歌面临健康部门商业化压力,苹果、IBM等诸多科技巨头的医疗保健项目似乎也发展得不够顺利。

近期有报道称,苹果正在缩减其健康部门的一个关键项目,即HealthHabit应用程序。这是一个应用程序,即苹果员工可以用来跟踪健身目标并与临床医生和教练沟通,50名员工在应用程序上花了很多时间,并且可能会在未来裁员,可能关闭该项目,或者它可以以缩小的方式继续。

而作为最早最重磅的科技巨头IBM也在医疗健康折戟,今年2月,据彭博社、华尔街日报等外媒报道,IBM或将出售旗下沃森健康(IBM Watson Health)业务。以帮助IBM专注于增长更快的云计算业务。IBM花了数十亿美元进行各式收购以建立Watson健康生态系统。IBM Watson Health 年收入约为 10 亿美元,但目前尚未实现盈利。

挫折和失望经常发生在巨头们在3.8万亿美元市场的医疗保健方面的早期努力。谷歌、亚马逊、苹果、IBM等公司的卫生项目产生营收与获得公司高层支持方面经常面临挑战。梅斯智库认为,沃森健康和其他一些苦苦挣扎的科技行业医疗人工智能项目过于雄心勃勃,试图回答广泛,复杂的健康相关问题,但患者隐私保护、缺乏数据收集标准都是阻碍,并无法解决医疗保健中最复杂的事情,实现智能诊疗仍然漫长。

尽管在医疗保健中科技应用面临诸多挑战,但我们相信行业仍将继续投资下去。庞大的万亿美元医疗保健市场规模是无限的。医疗普遍低效率状态下,采用新兴技术变革使医疗大大改善的想法显然非常诱人,但未来之路仍然较为漫长。

参考资料:

https://fortune.com/2021/08/20/google-health-chief-leaves-to-become-ceo-of-health-tech-company-cerner/

https://www.cerner.com/newsroom/cerner-announces-appointment-of-david-feinberg-md-as-president-and-chief-executive-officer

https://www.beckershospitalreview.com/healthcare-information-technology/a-breakdown-of-google-health-in-2021-15-things-leading-up-to-division-s-dismantling.html

https://www.cnbc.com/2021/08/19/google-health-boss-david-feinberg-leaves-to-become-cerner-ceo.html

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2022-03-23 shizhenshan
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2022-04-29 zhao4626
  3. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-23 isabellayj
  4. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-23 ms4000000284487957

    为了积分

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-22 weigq

    探索任何一个新行业都不容易。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-21 ms2658711348342440

    为了积分

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-21 仓央嘉措

    昨天恒瑞股票首次跌停……

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1861467, encodeId=45f1186146e01, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Mar 23 15:46:04 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699953, encodeId=167c16999535d, content=<a href='/topic/show?id=a05e81e516' target=_blank style='color:#2F92EE;'>#Google#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8175, encryptionId=a05e81e516, topicName=Google)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=930429982033, createdName=zhao4626, createdTime=Fri Apr 29 02:46:04 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537984, encodeId=f3e5153e984c2, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621927, encodeId=bbdf162192e60, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Mon Aug 23 08:46:04 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010470, encodeId=5c6d10104e067, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210823/6947e944846942cc88c887e028021a7c/6cf6a329c7d348ce8111e3eef797dcc2.jpg, createdBy=4a2c5435745, createdName=ms4000000284487957, createdTime=Mon Aug 23 02:33:06 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010252, encodeId=20891010252b8, content=探索任何一个新行业都不容易。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Sun Aug 22 10:08:12 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010161, encodeId=a65e101016118, content=为了积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Sat Aug 21 22:19:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010148, encodeId=01791010148b8, content=昨天恒瑞股票首次跌停……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Sat Aug 21 21:43:38 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010115, encodeId=6ff8101011554, content=期待明天会更好, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Aug 21 19:43:50 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-21 神盾医疗局局长Jack

    期待明天会更好

    0

相关资讯

收购2家公司,收揽**数据人才,苹果要把核心临床数据整合到iPhone上

随着数字医疗时代的来临,各类相关行业的初创公司如雨后春笋般涌现。它们有的成功了,更多的则是悄无声息地走入了死胡同,像是被巨浪压下的水花一样消失在数字医疗商业化的滚滚浪潮中。作为科技产业的龙头老大,苹果、谷歌等国际化大公司更注重于对行业资源的整合,不管是苹果发布的HealthKit、ResearchKit和CareKit还是谷歌夭折的Google Health,都是这一愿景下的产物。健康应用对苹

PNAS:苹果皮中的化合物可逆转多发性硬化症中的神经元损伤

《PNAS》上的一项新研究表明,在苹果、李子等水果的果皮和一些草药中发现的一种化合物熊果酸,可以减少对神经元的进一步损害,还有助于重建覆盖神经元的保护鞘,从而逆转这种损害。

圣诞吃个苹果,苹果颜色不同功效也不同

在市场上的苹果种类有很多,而不同种类的苹果就会有不同的颜色。与此同时,根据不同的颜色,苹果的功效也是不同的。今天,不仅要为大家介绍各种常见颜色苹果的营养价值,还有苹果的新吃法推荐给大家,快来看看吧。不同颜色苹果的功效红苹果。更有益心脏,提高记忆力,保持泌尿系统的健康。中医认为,红苹果降低血脂、软化血管的祛病作用更强,可保护心脑血管健康,老年人可以多吃一些。青苹果。具有养肝解毒的功效,并能对抗抑郁症

盘点:一天一苹果,医生远离我

根据联合国粮农组织统计,2013年全世界的苹果产量为8082万吨,超过葡萄的7718万吨,排世界第二位(第一位是香蕉:1.067亿吨)。毫无疑问,苹果是温带水果之王。 【1】稀苹果汁治疗轻度胃肠炎儿童效果好 加拿大的研究人员对6〜60个月患有胃肠炎轻度脱水的儿童进行了研究。 这些参与者被随机分配接受接受颜色匹配的半强度苹果汁/偏爱饮料(n=323)治疗或苹果味的电解质

科学家如何在苹果里长出人的耳朵?

渥太华大学的生物物理学家安德鲁·佩林(Andrew Pelling)将苹果变成一种可以生长人体组织的结构。

Stem Cell Reports:苹果竟会增强大脑功能?

“一天一苹果,医生远离我。” 的确有些道理。除了作为能量来源外,食物还会影响人体健康状况。